Oncolys BioPharma: Mass Ownership Report
Oncolys BioPharma: Announcements of the issuance of the 20th subscription rights (with exercise price adjustment clause and exercise suspension clause) through third-party allocation have been completed for payment.
Oncolys BioPharma: Announcements of individual stocks regarding the issuance of the 20th subscription rights by third-party allocation (with modification clause for exercise price and suspension clause for exercise) and the conclusion of the purchase agreement (commitment issue) of subscription rights.
Oncolys BioPharma: Supplementary explanatory materials regarding the issuance of the 20th subscription rights through third-party allocation.
Oncolys BioPharma: Securities registration statement (referencing method).
Oncolys BioPharma: Notice Concerning Issuance of New Shares as Stock Compensation with Transfer Restricted Shares
Oncolis Biopharma: Change Report (Stock Certificates Subject to Special Cases, etc.)
Oncolys BioPharma: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
Oncolys BioPharma: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
Oncolys BioPharma: Change Report
Oncolys BioPharma: Change Report
Oncolys BioPharma: Change Report
Oncolys BioPharma: Change Report
Oncolys BioPharma: Change Report
Oncolys BioPharma: Change Report
Oncolys BioPharma: Change Report
Oncolys BioPharma: Mass Ownership Report
Oncolys BioPharma: Notice Concerning Payment Completion Related to Issuance of the 19th Stock Acquisition Rights (with Exercise Price Amendment Clause) through Third-Party Allotment
Oncolys BioPharma: Notice Concerning Issuance of the 19th Stock Acquisition Rights (with Exercise Price Amendment Clause) and Conclusion of Facility Agreements (with Exercise Suspension Designation Clauses) through Third-Party Allotment
Oncolys BioPharma: Securities registration form (reference method)
No Data